83 related articles for article (PubMed ID: 6231787)
1. The effect of radioimmunosuppression on the development of low-dose streptozotocin diabetes.
Hahn HJ; Barnstorf K; Nadrowitz R; Besch W; Schmidt W
Acta Biol Med Ger; 1982; 41(12):1191-7. PubMed ID: 6231787
[TBL] [Abstract][Full Text] [Related]
2. The effect of irradiation on the development of low-dose streptozotocin diabetes in mice.
Hahn HJ; Barnstorf K; Nadrowitz R; Schmidt W
Diabete Metab; 1983 Mar; 9(1):42-4. PubMed ID: 6221960
[TBL] [Abstract][Full Text] [Related]
3. Plasma glucose and pancreatic insulin content in the early phase of streptozotocin-induced diabetes (preliminary results).
Hahn HJ; Hagen R; Knobloch C; Besch W
Acta Biol Med Ger; 1981; 40(1):83-5. PubMed ID: 6455026
[TBL] [Abstract][Full Text] [Related]
4. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
[TBL] [Abstract][Full Text] [Related]
5. Diabetes mellitus in mice induced by multiple subdiabetogenic doses of streptozotocin: age and sex dependence.
Kuttler B; Schneider E
Acta Biol Med Ger; 1982; 41(12):1199-1202. PubMed ID: 6231788
[TBL] [Abstract][Full Text] [Related]
6. Transgenic expression of interleukin 10 in the pancreas renders resistant mice susceptible to low dose streptozotocin-induced diabetes.
Mueller R; Lee MS; Sawyer SP; Sarvetnick N
J Autoimmun; 1996 Apr; 9(2):151-8. PubMed ID: 8738958
[TBL] [Abstract][Full Text] [Related]
7. Effect of cyclosporin A on low-dose streptozotocin diabetes in mice.
Kolb H; Oschilewski M; Schwab E; Oschilewski U; Kiesel U
Diabetes Res; 1985 Jul; 2(4):191-3. PubMed ID: 3910327
[TBL] [Abstract][Full Text] [Related]
8. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G
Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170
[TBL] [Abstract][Full Text] [Related]
9. The radical scavenger edaravone counteracts diabetes in multiple low-dose streptozotocin-treated mice.
Fukudome D; Matsuda M; Kawasaki T; Ago Y; Matsuda T
Eur J Pharmacol; 2008 Mar; 583(1):164-9. PubMed ID: 18291360
[TBL] [Abstract][Full Text] [Related]
10. Analysis of 22 immunomodulatory substances for efficacy in low-dose streptozotocin-induced diabetes.
Kolb H; Oschilewski M; Oschilewski U; Schwab E; Moumé CM; Greulich B; Burkart V; Zielasek J; Kiesel U
Diabetes Res; 1987 Sep; 6(1):21-7. PubMed ID: 3319352
[TBL] [Abstract][Full Text] [Related]
11. Methadone ameliorates multiple-low-dose streptozotocin-induced type 1 diabetes in mice.
Amirshahrokhi K; Dehpour AR; Hadjati J; Sotoudeh M; Ghazi-Khansari M
Toxicol Appl Pharmacol; 2008 Oct; 232(1):119-24. PubMed ID: 18671992
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous recovery of streptozotocin diabetes in mice.
Hartmann K; Besch W; Zühlke H
Exp Clin Endocrinol; 1989 May; 93(2-3):225-30. PubMed ID: 2528469
[TBL] [Abstract][Full Text] [Related]
13. Suppression of low-dose streptozotocin-induced diabetes by immunomodulatory lectins.
Kolb H; Oschilewski M; Schwab E; Greulich B; Roos P; Kiesel U
Diabetes Res; 1986 May; 3(4):183-6. PubMed ID: 3742941
[TBL] [Abstract][Full Text] [Related]
14. IL-23 leads to diabetes induction after subdiabetogenic treatment with multiple low doses of streptozotocin.
Mensah-Brown EP; Shahin A; Al-Shamisi M; Wei X; Lukic ML
Eur J Immunol; 2006 Jan; 36(1):216-23. PubMed ID: 16358360
[TBL] [Abstract][Full Text] [Related]
15. Preventative effects of the flowers of Inula britannica on autoimmune diabetes in C57BL/KsJ mice induced by multiple low doses of streptozotocin.
Kobayashi T; Song QH; Hong T; Kitamura H; Cyong JC
Phytother Res; 2002 Jun; 16(4):377-82. PubMed ID: 12112297
[TBL] [Abstract][Full Text] [Related]
16. Expression and immune response to islet antigens following treatment with low doses of streptozotocin in H-2d mice.
Herold KC; Baumann E; Vezys V; Buckingham F
J Autoimmun; 1997 Feb; 10(1):17-25. PubMed ID: 9080296
[TBL] [Abstract][Full Text] [Related]
17. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
Sternesjö J; Welsh N; Sandler S
Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
[TBL] [Abstract][Full Text] [Related]
18. A transcriptional inhibitor of TNF-alpha prevents diabetes induced by multiple low-dose streptozotocin injections in mice.
Holstad M; Sandler S
J Autoimmun; 2001 Jun; 16(4):441-7. PubMed ID: 11437492
[TBL] [Abstract][Full Text] [Related]
19. Detrimental effect of protracted hyperglycaemia on beta-cell neogenesis in a mouse murine model of diabetes.
Guz Y; Torres A; Teitelman G
Diabetologia; 2002 Dec; 45(12):1689-96. PubMed ID: 12488958
[TBL] [Abstract][Full Text] [Related]
20. Safe induction of diabetes by high-dose streptozotocin in pigs.
Hara H; Lin YJ; Zhu X; Tai HC; Ezzelarab M; Balamurugan AN; Bottino R; Houser SL; Cooper DK
Pancreas; 2008 Jan; 36(1):31-8. PubMed ID: 18192878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
